2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole

C114H115ClF3N27O10 — CID 158322444

About 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole

2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole (PubChem CID 158322444) has the molecular formula C114H115ClF3N27O10 and a molecular weight of 2115.80 g/mol. Its IUPAC name is 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole.

Molecular Properties

• Compound Name: 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole
• PubChem CID: 158322444
• Molecular Formula: C114H115ClF3N27O10
• Molecular Weight: 2115.80 g/mol
• Exact Mass: 2113.90
• IUPAC Name: 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole
• SMILES: COc1cccc(F)c1CN1CC(OC)C[C@@H](c2nnc(-c3ccc4[nH]nc(-c5ccc6nccn6c5)c4c3)o2)C1.COc1cccc(F)c1CN1CC(OC)C[C@@H](c2nnc(-c3ccc4[nH]nc(-c5ccc6nn(C)cc6c5)c4c3)o2)C1.COc1cccc(F)c1CN1CC(OC)C[C@@H](c2nnc(-c3ccc4[nH]nc(-c5cnn(C)c5)c4c3)o2)C1.Clc1cc(-c2n[nH]c3ccc(-c4nnc([C@@H]5CCCN(CC6CCCCC6)C5)o4)cc23)ccn1
• InChI: InChI=1S/C31H30FN7O3.C30H28FN7O3.C27H28FN7O3.C26H29ClN6O/c1-38-14-20-11-18(7-9-26(20)37-38)29-23-13-19(8-10-27(23)33-34-29)30-35-36-31(42-30)21-12-22(40-2)16-39(15-21)17-24-25(32)5-4-6-28(24)41-3;1-39-21-12-20(14-37(16-21)17-23-24(31)4-3-5-26(23)40-2)30-36-35-29(41-30)18-6-8-25-22(13-18)28(34-33-25)19-7-9-27-32-10-11-38(27)15-19;1-34-12-18(11-29-34)25-20-10-16(7-8-23(20)30-31-25)26-32-33-27(38-26)17-9-19(36-2)14-35(13-17)15-21-22(28)5-4-6-24(21)37-3;27-23-14-18(10-11-28-23)24-21-13-19(8-9-22(21)29-30-24)25-31-32-26(34-25)20-7-4-12-33(16-20)15-17-5-2-1-3-6-17/h4-11,13-14,21-22H,12,15-17H2,1-3H3,(H,33,34);3-11,13,15,20-21H,12,14,16-17H2,1-2H3,(H,33,34);4-8,10-12,17,19H,9,13-15H2,1-3H3,(H,30,31);8-11,13-14,17,20H,1-7,12,15-16H2,(H,29,30)/t21-,22?;20-,21?;17-,19?;20-/m1111/s1
• InChIKey: GOZZSOAJNVHPDW-TVIKESOXSA-N
• XLogP: 20.65
• TPSA: 404.57 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 33
• Rotatable Bonds: 26
• Heavy Atoms: 155
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2115.80
LogP ≤ 5	20.65
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	33

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole?

The IUPAC name of 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole (CID 158322444) is 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole.

What is the SMILES notation for 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole?

The canonical SMILES for 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole is COc1cccc(F)c1CN1CC(OC)C[C@@H](c2nnc(-c3ccc4[nH]nc(-c5ccc6nccn6c5)c4c3)o2)C1.COc1cccc(F)c1CN1CC(OC)C[C@@H](c2nnc(-c3ccc4[nH]nc(-c5ccc6nn(C)cc6c5)c4c3)o2)C1.COc1cccc(F)c1CN1CC(OC)C[C@@H](c2nnc(-c3ccc4[nH]nc(-c5cnn(C)c5)c4c3)o2)C1.Clc1cc(-c2n[nH]c3ccc(-c4nnc([C@@H]5CCCN(CC6CCCCC6)C5)o4)cc23)ccn1.

What is the InChIKey of 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole?

The InChIKey is GOZZSOAJNVHPDW-TVIKESOXSA-N. The full InChI is InChI=1S/C31H30FN7O3.C30H28FN7O3.C27H28FN7O3.C26H29ClN6O/c1-38-14-20-11-18(7-9-26(20)37-38)29-23-13-19(8-10-27(23)33-34-29)30-35-36-31(42-30)21-12-22(40-2)16-39(15-21)17-24-25(32)5-4-6-28(24)41-3;1-39-21-12-20(14-37(16-21)17-23-24(31)4-3-5-26(23)40-2)30-36-35-29(41-30)18-6-8-25-22(13-18)28(34-33-25)19-7-9-27-32-10-11-38(27)15-19;1-34-12-18(11-29-34)25-20-10-16(7-8-23(20)30-31-25)26-32-33-27(38-26)17-9-19(36-2)14-35(13-17)15-21-22(28)5-4-6-24(21)37-3;27-23-14-18(10-11-28-23)24-21-13-19(8-9-22(21)29-30-24)25-31-32-26(34-25)20-7-4-12-33(16-20)15-17-5-2-1-3-6-17/h4-11,13-14,21-22H,12,15-17H2,1-3H3,(H,33,34);3-11,13,15,20-21H,12,14,16-17H2,1-2H3,(H,33,34);4-8,10-12,17,19H,9,13-15H2,1-3H3,(H,30,31);8-11,13-14,17,20H,1-7,12,15-16H2,(H,29,30)/t21-,22?;20-,21?;17-,19?;20-/m1111/s1.

What are the key properties of 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole?

2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole has a molecular weight of 2115.80 g/mol, XLogP of 20.65, 26 rotatable bonds, 4 hydrogen bond donors, and 33 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[3-(2-chloro-4-pyridinyl)-1H-indazol-5-yl]-5-[(3R)-1-(cyclohexylmethyl)piperidin-3-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-(3-imidazo[1,2-a]pyridin-6-yl-1H-indazol-5-yl)-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(2-methylindazol-5-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole;2-[(3R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methoxypiperidin-3-yl]-5-[3-(1-methylpyrazol-4-yl)-1H-indazol-5-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 158322444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).